Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
SEMA6C Biologics Sequence Review Report 2026: Semaphorin-6C Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of SEMA6C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
SEMA6A Biologics Sequence Review Report 2026: Semaphorin-6A Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of SEMA6A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
SEMA5B Biologics Sequence Review Report 2026: Semaphorin-5B Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of SEMA5B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LRP8 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 8 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of LRP8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPRC6A Biologics Sequence Review Report 2026: G protein-coupled receptor family C group 6 member A Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of GPRC6A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ICAM5 Biologics Sequence Review Report 2026: Intercellular adhesion molecule 5 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ICAM5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL16 Biologics Sequence Review Report 2026: Pro-interleukin-16 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of IL16 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ERBB4 Biologics Sequence Review Report 2026: Receptor tyrosine-protein kinase erbB-4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ERBB4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPRASP1 Biologics Sequence Review Report 2026: G protein-coupled receptor-associated sorting protein 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of GPRASP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ERBB3 Biologics Sequence Review Report 2026: Receptor tyrosine-protein kinase erbB-3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ERBB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR158 Biologics Sequence Review Report 2026: Metabotropic glycine receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of GPR158 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ERBB2 Biologics Sequence Review Report 2026: Receptor tyrosine-protein kinase erbB-2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ERBB2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
57
58
59
60
61
>>
1620
>